![Brian Connolly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Connolly
Technik-/Wissenschafts-/F&E-Leiter bei
SPYRE THERAPEUTICS, INC.
Profil
Brian Connolly is Chief Technical Officer at Spyre Therapeutics, Inc. since 2023.
Formerly, Mr. Connolly was Associate Director at Achaogen, Inc. from 2017 to 2018, Senior Director-Operations at ViewPoint Therapeutics, Inc. from 2019 to 2020, Senior Director-CMC Development & Manufacturing at Catalyst Biosciences, Inc. from 2020 to 2021, and VP, Head-Chemistry, Manufacturing & Controls at Prometheus Biosciences, Inc. from 2021 to 2023.
Mr. Connolly completed undergraduate studies at the University of California.
Aktive Positionen von Brian Connolly
| Unternehmen | Position | Beginn |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.11.2023 |
Ehemalige bekannte Positionen von Brian Connolly
| Unternehmen | Position | Ende |
|---|---|---|
| PROMETHEUS BIOSCIENCES, INC. | Corporate Officer/Principal | 01.10.2023 |
| CATALYST BIOSCIENCES | Corporate Officer/Principal | 01.01.2021 |
Viewpoint Therapeutics, Inc.
 Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Develops non-surgical treatments for eye diseases | Geschäftsführer | 01.01.2020 |
| ACHAOGEN | Corporate Officer/Principal | 01.01.2018 |
Ausbildung von Brian Connolly
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
11
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Develops non-surgical treatments for eye diseases | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops medicines for immune-mediated diseases | Health Technology |
